A multicenter phase II study of docetaxel, oxaliplatin, and bevacizumab in first-line therapy for unresectable locally advanced or metastatic non-squamous cell histology non-small-cell lung cancer (NSCLC)
Titel:
A multicenter phase II study of docetaxel, oxaliplatin, and bevacizumab in first-line therapy for unresectable locally advanced or metastatic non-squamous cell histology non-small-cell lung cancer (NSCLC)
Auteur:
Raez, Luis E. Santos, Edgardo S. Webb, R. Timothy Wade, James Brito, Roger A. Karr, Melissa Kennah, Andra Childs, Barrett H.